GLP-1 & Weight Management

Retatrutide

Retatrutide — research-grade reference material, supplied in multiple sizes.

Product Code: RTD
Purity: 99%
Form: Lyophilized powder
Packaging: 10mg

Ships from multiple warehouses — typically 2–5 business days to nearby destinations. International orders coordinated per destination.

No prices are published. Available scope, specifications and documentation are confirmed during specification review. Supplied for research and analytical use by qualified organizations — see our Research Use Only policy.

Specification

Purity specification: 99%
Appearance: White to off-white lyophilized powder
Solubility: Reconstitutes in sterile or bacteriostatic water
Counter ion: Acetate
Form: Lyophilized Powder
Available sizes: 5mg × 10vials, 10mg × 10vials, 15mg × 10vials, 20mg × 10vials, 30mg × 10vials, 60mg × 10vials
Storage: Store lyophilized powder at −20°C in a sealed container, protected from light and moisture. Stable for 24+ months unreconstituted. Keep reconstituted material refrigerated and minimise freeze–thaw cycles.
MOQ: On request

Research Applications

Research use: retatrutide is a GIP/GLP-1/glucagon receptor triagonist used to study the integrated metabolic effects of triple incretin agonism.
Studied in metabolic research for body weight reduction through combined effects on appetite, energy expenditure, and lipid metabolism.
Used in metabolic disease models to investigate glycemic control and hepatic steatosis reduction beyond dual-agonist effects.
In research development for metabolic , supporting research on long-acting peptide-based research applications for metabolic syndrome.

Triple target GIP/GLP-1/Glucagon agonist, currently the strongest metabolic-research potential